Table 7.9 <strong>Europe</strong> by drug type <strong><strong>an</strong>d</strong> country: <strong>an</strong>tipsychotics – all All <strong>an</strong>tipsychotics (SU per 1000 population) 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Austria 6,799 6,756 7,008 7,239 7,262 7,298 7,430 7,518 7,759 8,165 Belgium 8,954 8,726 8,768 8,752 9,034 9,031 9,098 8,774 8,868 9,040 Denmark* – – – – – – – – – – Finl<strong><strong>an</strong>d</strong> 19,277 19,744 19,741 19,749 19,343 19,016 18,900 18,617 18,273 17,975 Fr<strong>an</strong>ce 11,099 11,026 10,535 10,687 10,493 10,155 10,074 10,073 10,071 9,868 Germ<strong>an</strong>y 9,236 9,261 9,492 9,670 9,761 9,791 9,740 9,726 9,951 10,310 Greece*** 5,986 5,721 5,519 6,165 5,946 6,058 6,705 7,102 7,563 8,466 Irel<strong><strong>an</strong>d</strong>*** 5,279 5,587 5,816 6,198 6,412 6,476 6,613 6,854 6,600 6,768 Italy 4,292 4,296 4,506 4,600 4,638 4,696 4,888 5,302 5,697 5,558 Luxembourg*** 5,017 5,101 5,575 5,606 5,537 5,994 5,964 5,731 5,748 5,861 Netherl<strong><strong>an</strong>d</strong>s** – – – – – – – 2,076 4,228 4,275 Portugal*** 6,145 6,525 7,078 7,650 7,826 8,039 8,460 9,268 9,600 9,881 Spain** 6,284 6,587 6,902 7,277 7,657 7,907 8,640 8,996 9,367 9,615 Sweden* – – – – – – – – – – United Kingdom 4,160 4,162 4,504 4,231 4,163 3,938 3,712 3,379 4,045 3,838 * No IMS data available. ** No IMS data available for Spain (hospital) until 1999 <strong><strong>an</strong>d</strong> from Netherl<strong><strong>an</strong>d</strong>s (retail) until 2000. *** Data from retail p<strong>an</strong>els only. Source: IMS Health Third Study. See Note 1.
Table 7.10 <strong>Europe</strong> by drug type <strong><strong>an</strong>d</strong> country: <strong>an</strong>tipsychotics – typical Typical <strong>an</strong>tipsychotics (SU per 1000 population) 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Austria 6,388 6,292 6,477 6,606 6,444 6,162 5,825 5,541 5,375 5,294 Belgium 8,954 8,726 8,768 8,620 8,577 8,380 8,096 7,337 6,969 6,511 Denmark* – – – – – – – – – – Finl<strong><strong>an</strong>d</strong> 18,475 18,776 18,448 18,195 17,383 16,685 15,877 14,800 13,472 12,118 Fr<strong>an</strong>ce 10,546 10,376 9,829 9,780 9,406 8,891 8,637 8,519 8,231 7,756 Germ<strong>an</strong>y 8,808 8,768 8,945 9,034 9,012 8,882 8,624 8,384 8,150 8,040 Greece*** 5,948 5,517 5,201 5,701 5,310 5,132 5,341 5,186 4,915 4,773 Irel<strong><strong>an</strong>d</strong>*** 5,279 5,556 5,727 6,015 6,050 5,848 5,679 5,488 4,212 3,663 Italy 4,288 4,196 4,241 4,086 3,857 3,665 3,570 3,611 3,360 3,055 Luxembourg*** 4,990 5,060 5,478 5,410 5,267 5,490 5,176 4,590 4,297 3,991 Netherl<strong><strong>an</strong>d</strong>s** – – – – – – – 1,406 2,726 2,564 Portugal*** 5,500 5,781 6,180 6,680 6,756 6,876 7,113 7,374 7,153 6,845 Spain** 6,269 6,454 6,606 6,861 6,970 6,761 7,035 6,943 6,772 6,466 Sweden* – – – – – – – – – – United Kingdom 4,160 4,162 4,504 4,231 4,163 3,905 3,612 3,226 3,858 3,620 * No IMS data available. ** No IMS data available for Spain (hospital) until 1999 <strong><strong>an</strong>d</strong> from Netherl<strong><strong>an</strong>d</strong>s (retail) until 2000. *** Data from retail p<strong>an</strong>els only. Source: IMS Health Third Study. See Note 1.
- Page 1 and 2:
European Observatory on Health Syst
- Page 3 and 4:
The European Observatory on Health
- Page 5 and 6:
Open University Press McGraw-Hill E
- Page 7 and 8:
European Observatory on Health Syst
- Page 9 and 10:
viii Contents five six The evidence
- Page 11 and 12:
List of tables 2.1 Beds in state ps
- Page 13 and 14:
List of figures 4.1 The production
- Page 15 and 16:
List of boxes 3.1 A personal testim
- Page 17 and 18:
List of contributors Francesco Amad
- Page 19 and 20:
xviii List of contributors Viviane
- Page 21 and 22:
Series editors’ introduction Euro
- Page 23 and 24:
Foreword Mental health may be the m
- Page 25 and 26:
Foreword by the Minister of Health
- Page 27 and 28:
Acknowledgements This volume is par
- Page 29 and 30:
chapter one Mental health policy an
- Page 31 and 32:
An overview 3 agencies (see Chapter
- Page 33 and 34:
An overview 5 Funding In broad term
- Page 35 and 36:
An overview 7 Social inclusion and
- Page 37 and 38:
An overview 9 actions such as inter
- Page 39 and 40:
An overview 11 of symptom alleviati
- Page 41 and 42:
An overview 13 Kessler, R.C., Demle
- Page 43 and 44:
chapter two The historical developm
- Page 45 and 46:
Historical development of mental he
- Page 47 and 48:
Historical development of mental he
- Page 49 and 50:
Historical development of mental he
- Page 51 and 52:
Historical development of mental he
- Page 53 and 54:
Historical development of mental he
- Page 55 and 56:
A lack of historical continuity His
- Page 57 and 58:
Historical development of mental he
- Page 59 and 60:
Historical development of mental he
- Page 61 and 62:
Historical development of mental he
- Page 63 and 64:
Tackling social exclusion 35 • in
- Page 65 and 66:
Tackling social exclusion 37 networ
- Page 67 and 68:
Tackling social exclusion 39 regula
- Page 69 and 70:
Tackling social exclusion 41 where
- Page 71 and 72:
Tackling social exclusion 43 and Sw
- Page 73 and 74:
Tackling social exclusion 45 addres
- Page 75 and 76:
Tackling social exclusion 47 than o
- Page 77 and 78:
Tackling social exclusion 49 in thi
- Page 79 and 80:
Tackling social exclusion 51 not ho
- Page 81 and 82:
Tackling social exclusion 53 Box 3.
- Page 83 and 84:
Tackling social exclusion 55 Conclu
- Page 85 and 86:
Tackling social exclusion 57 Disabi
- Page 87 and 88:
Tackling social exclusion 59 Read,
- Page 89 and 90:
Financing and funding 61 problems h
- Page 91 and 92:
Financing and funding 63 provides a
- Page 93 and 94:
Financing and funding 65 recognizin
- Page 95 and 96:
Financing and funding 67 care docto
- Page 97 and 98:
Financing and funding 69 Trends in
- Page 99 and 100:
Financing and funding 71 employment
- Page 101 and 102:
Financing and funding 73 kind, cove
- Page 103 and 104:
Financing and funding 75 emphasis o
- Page 105 and 106:
Financing and funding 77 provided i
- Page 107 and 108:
Financing and funding 79 for differ
- Page 109 and 110:
Financing and funding 81 budgets in
- Page 111 and 112:
Financing and funding 83 Europe or
- Page 113 and 114:
Financing and funding 85 the famili
- Page 115 and 116:
Financing and funding 87 of further
- Page 117 and 118:
Financing and funding 89 mental hea
- Page 119 and 120:
Financing and funding 91 community
- Page 121 and 122:
Financing and funding 93 Available
- Page 123 and 124:
Financing and funding 95 Basu, A. (
- Page 125 and 126:
Financing and funding 97 of interve
- Page 127 and 128:
Financing and funding 99 World Heal
- Page 129 and 130:
The evidence base 101 result of pub
- Page 131 and 132:
The evidence base 103 campaigns, it
- Page 133 and 134:
The evidence base 105 using health
- Page 135 and 136: Table 5.1 A matrix of evidence Rese
- Page 137 and 138: Identifying needs using epidemiolog
- Page 139 and 140: The evidence base 111 facilitate gl
- Page 141 and 142: The evidence base 113 Learning from
- Page 143 and 144: The evidence base 115 sources of ev
- Page 145 and 146: The evidence base 117 Europe, and i
- Page 147 and 148: The evidence base 119 to Policy pro
- Page 149 and 150: The evidence base 121 Finally, it i
- Page 151 and 152: The evidence base 123 Lavis, J., Ro
- Page 153 and 154: The evidence base 125 World Health
- Page 155 and 156: The treatment of mental disorders 1
- Page 157 and 158: The treatment of mental disorders 1
- Page 159 and 160: The treatment of mental disorders 1
- Page 161 and 162: The treatment of mental disorders 1
- Page 163 and 164: The treatment of mental disorders 1
- Page 165 and 166: The treatment of mental disorders 1
- Page 167 and 168: The treatment of mental disorders 1
- Page 169 and 170: The treatment of mental disorders 1
- Page 171 and 172: The treatment of mental disorders 1
- Page 173 and 174: The treatment of mental disorders 1
- Page 175 and 176: Psychopharmaceuticals in Europe 147
- Page 177 and 178: Psychopharmaceuticals in Europe 149
- Page 179 and 180: Psychopharmaceuticals in Europe 151
- Page 181 and 182: Psychopharmaceuticals in Europe 153
- Page 183 and 184: Table 7.6 Europe by drug type and c
- Page 185: Table 7.8 Europe by drug type and c
- Page 189 and 190: Table 7.12 Europe by drug type and
- Page 191 and 192: Table 7.14 Europe comparative presc
- Page 193 and 194: Psychopharmaceuticals in Europe 165
- Page 195 and 196: Table 7.20 Decline in psychiatric i
- Page 197 and 198: Psychopharmaceuticals in Europe 169
- Page 199 and 200: Psychopharmaceuticals in Europe 171
- Page 201 and 202: Psychopharmaceuticals in Europe 173
- Page 203 and 204: Psychopharmaceuticals in Europe 175
- Page 205 and 206: Psychopharmaceuticals in Europe 177
- Page 207 and 208: Psychopharmaceuticals in Europe 179
- Page 209 and 210: Psychopharmaceuticals in Europe 181
- Page 211 and 212: Psychopharmaceuticals in Europe 183
- Page 213 and 214: Psychopharmaceuticals in Europe 185
- Page 215 and 216: Psychopharmaceuticals in Europe 187
- Page 217 and 218: Promotion and prevention 189 Mental
- Page 219 and 220: Promotion and prevention 191 Box 8.
- Page 221 and 222: Promotion and prevention 193 risk o
- Page 223 and 224: Promotion and prevention 195 and th
- Page 225 and 226: Promotion and prevention 197 (Üstu
- Page 227 and 228: Promotion and prevention 199 and un
- Page 229 and 230: Promotion and prevention 201 The li
- Page 231 and 232: Promotion and prevention 203 income
- Page 233 and 234: Promotion and prevention 205 implem
- Page 235 and 236: Promotion and prevention 207 When d
- Page 237 and 238:
Promotion and prevention 209 health
- Page 239 and 240:
Promotion and prevention 211 Murphy
- Page 241 and 242:
Promotion and prevention 213 Vuori,
- Page 243 and 244:
chapter nine Common mental health p
- Page 245 and 246:
Mental health disorders in primary
- Page 247 and 248:
Mental health problems in primary c
- Page 249 and 250:
Mental health problems in primary c
- Page 251 and 252:
Mental health problems in primary c
- Page 253 and 254:
Mental health problems in primary c
- Page 255 and 256:
Mental health problems in primary c
- Page 257 and 258:
Mental health problems in primary c
- Page 259 and 260:
Mental health problems in primary c
- Page 261 and 262:
Mental health problems in primary c
- Page 263 and 264:
chapter ten Reforms in community ca
- Page 265 and 266:
Table 10.1 Mental health care in th
- Page 267 and 268:
Reforms in community care 239 syste
- Page 269 and 270:
Reforms in community care 241 integ
- Page 271 and 272:
Reforms in community care 243 In 19
- Page 273 and 274:
Reforms in community care 245 Secon
- Page 275 and 276:
Reforms in community care 247 must
- Page 277 and 278:
Reforms in community care 249 Goldb
- Page 279 and 280:
Addiction and alcohol 251 (Brown et
- Page 281 and 282:
Addiction and alcohol 253 Figure 11
- Page 283 and 284:
Addiction and alcohol 255 Table 11.
- Page 285 and 286:
Addiction and alcohol 257 Some stud
- Page 287 and 288:
Addiction and alcohol 259 availabil
- Page 289 and 290:
Addiction and alcohol 261 Table 11.
- Page 291 and 292:
Addiction and alcohol 263 Hours and
- Page 293 and 294:
Addiction and alcohol 265 College s
- Page 295 and 296:
Addiction and alcohol 267 Figure 11
- Page 297 and 298:
Addiction and alcohol 269 Figure 11
- Page 299 and 300:
Addiction and alcohol 271 Figure 11
- Page 301 and 302:
Addiction and alcohol 273 Alcohol t
- Page 303 and 304:
Addiction and alcohol 275 developme
- Page 305 and 306:
Addiction and alcohol 277 Greenfiel
- Page 307 and 308:
Addiction and alcohol 279 World Hea
- Page 309 and 310:
Housing and employment 281 European
- Page 311 and 312:
Housing and employment 283 to a lif
- Page 313 and 314:
Housing and employment 285 relative
- Page 315 and 316:
Housing and employment 287 comprise
- Page 317 and 318:
Housing and employment 289 treatmen
- Page 319 and 320:
Housing and employment 291 rented h
- Page 321 and 322:
Housing and employment 293 occupati
- Page 323 and 324:
Housing and employment 295 market;
- Page 325 and 326:
Housing and employment 297 Table 12
- Page 327 and 328:
Housing and employment 299 Return t
- Page 329 and 330:
Effectiveness of pre-vocational and
- Page 331 and 332:
Housing and employment 303 where re
- Page 333 and 334:
Housing and employment 305 mental h
- Page 335 and 336:
Housing and employment 307 S.M. (20
- Page 337 and 338:
A human rights perspective 309 Nor
- Page 339 and 340:
Monitoring compliance with the inte
- Page 341 and 342:
A human rights perspective 313 Ment
- Page 343 and 344:
A human rights perspective 315 Equa
- Page 345 and 346:
A human rights perspective 317 Last
- Page 347 and 348:
A human rights perspective 319 Comb
- Page 349 and 350:
A human rights perspective 321 segr
- Page 351 and 352:
A human rights perspective 323 The
- Page 353 and 354:
A human rights perspective 325 •
- Page 355 and 356:
A human rights perspective 327 ensu
- Page 357 and 358:
A human rights perspective 329 •
- Page 359 and 360:
A human rights perspective 331 Arti
- Page 361 and 362:
A human rights perspective 333 Refe
- Page 363 and 364:
A human rights perspective 335 Will
- Page 365 and 366:
The user and survivor movement 337
- Page 367 and 368:
The user and survivor movement 339
- Page 369 and 370:
The user and survivor movement 341
- Page 371 and 372:
The user and survivor movement 343
- Page 373 and 374:
The user and survivor movement 345
- Page 375 and 376:
The user and survivor movement 347
- Page 377 and 378:
The user and survivor movement 349
- Page 379 and 380:
The user and survivor movement 351
- Page 381 and 382:
The user and survivor movement 353
- Page 383 and 384:
The user and survivor movement 355
- Page 385 and 386:
Care of asylum seekers and refugees
- Page 387 and 388:
Care of asylum seekers and refugees
- Page 389 and 390:
Care of asylum seekers and refugees
- Page 391 and 392:
Care of asylum seekers and refugees
- Page 393 and 394:
Care of asylum seekers and refugees
- Page 395 and 396:
Care of asylum seekers and refugees
- Page 397 and 398:
generic local team or psychiatric h
- Page 399 and 400:
Care of asylum seekers and refugees
- Page 401 and 402:
Care of asylum seekers and refugees
- Page 403 and 404:
Carers and families 375 In this cha
- Page 405 and 406:
Carers and families 377 impact they
- Page 407 and 408:
Carers and families 379 2002). In a
- Page 409 and 410:
Carers and families 381 conducted i
- Page 411 and 412:
Carers and families 383 Interventio
- Page 413 and 414:
Carers and families 385 Child careg
- Page 415 and 416:
Carers and families 387 subject to
- Page 417 and 418:
Carers and families 389 Conclusion
- Page 419 and 420:
Carers and families 391 Cohen, C.A.
- Page 421 and 422:
Carers and families 393 in long-ter
- Page 423 and 424:
Carers and families 395 care in rel
- Page 425 and 426:
chapter seventeen Mental health pol
- Page 427 and 428:
Policy in former eastern bloc count
- Page 429 and 430:
Policy in former eastern bloc count
- Page 431 and 432:
Policy in former eastern bloc count
- Page 433 and 434:
Policy in former eastern bloc count
- Page 435 and 436:
Policy in former eastern bloc count
- Page 437 and 438:
Policy in former eastern bloc count
- Page 439 and 440:
Policy in former eastern bloc count
- Page 441 and 442:
Policy in former eastern bloc count
- Page 443 and 444:
Policy in former eastern bloc count
- Page 445 and 446:
Policy in former eastern bloc count
- Page 447 and 448:
Policy in former eastern bloc count
- Page 449 and 450:
Table 17.1 General information and
- Page 451 and 452:
Policy in former eastern bloc count
- Page 453 and 454:
Policy in former eastern bloc count
- Page 455 and 456:
Box 18.1 Recommendations in The Wor
- Page 457 and 458:
The WHO perspective 429 isolation,
- Page 459 and 460:
The WHO perspective 431 high when c
- Page 461 and 462:
The WHO perspective 433 Key issues
- Page 463 and 464:
The WHO perspective 435 Box 18.2 Qu
- Page 465 and 466:
The WHO perspective 437 services is
- Page 467 and 468:
The WHO perspective 439 Desjarlais,
- Page 469 and 470:
Index abuse of psychiatry, eastern
- Page 471 and 472:
Index 443 community care ECHR, 321
- Page 473 and 474:
Index 445 European countries commun
- Page 475 and 476:
Index 447 initiatives, discriminati
- Page 477 and 478:
Index 449 applying principles, 317-
- Page 479 and 480:
Index 451 policy, 228-9 practice, 2
- Page 481 and 482:
Related books from Open University
- Page 483:
PURCHASING TO IMPROVE HEALTH SYSTEM